Skip to content

GMP

How Personnel, Material and Waste Flows Shape Pharmaceutical Facilities

In preparation
StatusIn preparation

This article is in preparation.

The topic is planned and the article has not been written yet. Nothing on this page is published technical guidance.

What it will cover

This article will examine how personnel, material, product, and waste routes are mapped at concept stage: gowning sequences, airlock and pass-through placement, and the separation of clean and return routes. It will also explain why these decisions are hard to reverse once structure and HVAC zoning follow the layout.

Working on this topic now?

If this question is live on your project, you do not need to wait for the article. Tell us about the facility and we can discuss it directly.

Related topics

All insights
  • 01GMP

    In preparation

    How GMP Gap Assessment Becomes a CAPA Plan

    This article will examine how findings from a GMP gap assessment are captured, classified by risk, and turned into engineering responses with defined evidence, owners, and verification steps. It will also explain why a CAPA plan needs closeout evidence rather than a statement that an action was taken.

  • 02Facility Planning

    In preparation

    How to Start Planning a Pharmaceutical Factory

    This article will examine the first decisions behind a new pharmaceutical plant: product portfolio and dosage forms, sterile or nonsterile scope, capacity and shift assumptions, site constraints, and the regulatory framework of the target markets. It will also explain how these inputs become a brief that design can build on.

  • 03Pharma Engineering

    In preparation

    Concept vs Basic vs Detailed Engineering

    This article will examine what each engineering phase is expected to decide and deliver, from zoning and flow strategy at concept stage, through system definitions, equipment lists, and layouts in basic engineering, to coordinated construction drawings and specifications in detailed engineering.

Next step

Planning a pharmaceutical project?

Share the product type, the current stage and the main constraints. We will respond with a proposed scope and next steps.

+20 101 171 1700